142 related articles for article (PubMed ID: 6568787)
1. Factor D of the alternative pathway of bovine complement: isolation and characterization.
Menger M; Aston WP
Vet Immunol Immunopathol; 1984 Oct; 7(3-4):325-36. PubMed ID: 6568787
[TBL] [Abstract][Full Text] [Related]
2. A simple isolation procedure for functionally pure components of the bovine alternative complement pathway (ACP) C3 convertase and bovine conglutinin (K).
Phipps DJ; Aston WP
Vet Immunol Immunopathol; 1988 Oct; 19(3-4):251-8. PubMed ID: 3252617
[TBL] [Abstract][Full Text] [Related]
3. Hybrid proteins of Cobra Venom Factor and cobra C3: tools to identify functionally important regions in Cobra Venom Factor.
Hew BE; Wehrhahn D; Fritzinger DC; Vogel CW
Toxicon; 2012 Sep; 60(4):632-47. PubMed ID: 22609532
[TBL] [Abstract][Full Text] [Related]
4. Isolation and partial characterization of bovine and equine factor D.
Blanchard DB; Leid RW
Mol Immunol; 1984 Oct; 21(10):869-76. PubMed ID: 6568410
[TBL] [Abstract][Full Text] [Related]
5. A cobra venom factor (CVF)-induced C3 convertase activity in the hemolymph of Galleria mellonella.
Phipps D; Menger M; Chadwick JS; Aston WP
Dev Comp Immunol; 1987; 11(1):37-46. PubMed ID: 3647909
[TBL] [Abstract][Full Text] [Related]
6. [Effective method of simultaneous isolation from human serum of highly purified factors B and D of the alternative pathway of complement activation].
Soliakov LS; Kozlov LV
Bioorg Khim; 1983 Apr; 9(4):462-9. PubMed ID: 6567468
[TBL] [Abstract][Full Text] [Related]
7. Factor D of the alternative pathway of human complement. Purification, alignment and N-terminal amino acid sequences of the major cyanogen bromide fragments, and localization of the serine residue at the active site.
Johnson DM; Gagnon J; Reid KB
Biochem J; 1980 Jun; 187(3):863-74. PubMed ID: 6821372
[TBL] [Abstract][Full Text] [Related]
8. The activation of the alternative pathway C3 convertase by human plasma kallikrein.
DiScipio RG
Immunology; 1982 Mar; 45(3):587-95. PubMed ID: 6916710
[TBL] [Abstract][Full Text] [Related]
9. Isolation of the fifth component of the bovine complement system.
Aston WP; Mhatre A; Macrae J
Vet Immunol Immunopathol; 1990 Apr; 24(4):301-12. PubMed ID: 2140216
[TBL] [Abstract][Full Text] [Related]
10. Site-specific activation of the alternative pathway of complement. Synthesis of a hybrid molecule consisting of antibody and cobra venom factor.
Parker CJ; White VF; Falk RJ
Complement; 1986; 3(4):223-35. PubMed ID: 3643079
[TBL] [Abstract][Full Text] [Related]
11. Structure and function of recombinant cobra venom factor.
Kock MA; Hew BE; Bammert H; Fritzinger DC; Vogel CW
J Biol Chem; 2004 Jul; 279(29):30836-43. PubMed ID: 15131128
[TBL] [Abstract][Full Text] [Related]
12. [Formation of classical C3 convertase during the alternative pathway of human complement activation].
Kozlov LV; Shibanova ED; Zinchenko AA
Biokhimiia; 1987 Apr; 52(4):660-6. PubMed ID: 3647798
[TBL] [Abstract][Full Text] [Related]
13. New synthetic inhibitor to the alternative complement pathway.
Ikari N; Sakai Y; Hitomi Y; Fujii S
Immunology; 1983 Aug; 49(4):685-91. PubMed ID: 6553561
[TBL] [Abstract][Full Text] [Related]
14. Ultrastructure of cobra venom factor-dependent C3/C5 convertase and its zymogen, factor B of human complement.
Smith CA; Vogel CW; Müller-Eberhard HJ
J Biol Chem; 1982 Sep; 257(17):9879-82. PubMed ID: 6921201
[TBL] [Abstract][Full Text] [Related]
15. Complement activation by heat-killed human kidney cells: formation, activity, and stabilization of cell-bound C3 convertases.
Baker PJ; Adler S; Yang Y; Couser WG
J Immunol; 1984 Aug; 133(2):877-81. PubMed ID: 6376629
[TBL] [Abstract][Full Text] [Related]
16. Isolation of bovine complement factor H.
Mhatre A; Aston WP
Vet Immunol Immunopathol; 1987 Apr; 14(4):357-75. PubMed ID: 2955562
[TBL] [Abstract][Full Text] [Related]
17. The alternative pathway C3/C5 convertase: chemical basis of factor B activation.
Lesavre PH; Hugli TE; Esser AF; Müller-Eberhard HJ
J Immunol; 1979 Aug; 123(2):529-34. PubMed ID: 458145
[TBL] [Abstract][Full Text] [Related]
18. Complement activation in factor D-deficient mice.
Xu Y; Ma M; Ippolito GC; Schroeder HW; Carroll MC; Volanakis JE
Proc Natl Acad Sci U S A; 2001 Dec; 98(25):14577-82. PubMed ID: 11724962
[TBL] [Abstract][Full Text] [Related]
19. Isolation and characterization of the third component of bovine complement.
Menger M; Aston WP
Vet Immunol Immunopathol; 1985 Dec; 10(4):317-31. PubMed ID: 3832572
[TBL] [Abstract][Full Text] [Related]
20. The cobra venom factor-dependent C3 convertase of human complement. A kinetic and thermodynamic analysis of a protease acting on its natural high molecular weight substrate.
Vogel CW; Müller-Eberhard HJ
J Biol Chem; 1982 Jul; 257(14):8292-9. PubMed ID: 6919543
[No Abstract] [Full Text] [Related]
[Next] [New Search]
